Recent Advances in Detection and Biosensors

Posted by

SELECTBIO

Many extravagant claims have been made in the past two decades about the likely impact of biosensors on the diagnostics industry: In reality, the current market size for biosensors represents ~14% of the global diagnostics market and is dominated entirely by sensors for one analyte, glucose. This presentation looks at the need for, and advantages of biosensors, the technology that has been developed over the past two decades to address these perceived needs, but, in reality, has failed to do so, and describes newer technologies which may circumvent the problems and suggests how they are likely to have a much more significant impact in the future, particularly in sectors such as medical diagnostics and biodetection. Examples of optical and acoustic technologies will be given.